Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MERIDIA
- Studying the Effects of Sibutramine on Eating Behavior
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
- Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
- Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
- Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects
- Treatment of Binge Eating in Obese Patients in Primary Care
- A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
- Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
- A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
- A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
- A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients
Clinical trials list
click for details